Literature DB >> 29267063

Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria.

Maryam Ibrahim Buba1, Mahmood Muazu Dalhat1, Patrick Mboya Nguku1, Ndadilnasiya Waziri1, Jibreel Omar Mohammad1, Idriss Mohammed Bomoi1, Amaka Pamela Onyiah1, Jude Onwujei1, Muhammad Shakir Balogun1, Adebobola Toluwalashe Bashorun1, Peter Nsubuga1, Abdulsalami Nasidi1.   

Abstract

OBJECTIVES: To determine factors associated with mortality among confirmed Lassa fever cases.
METHODS: We reviewed line lists and clinical records of laboratory-confirmed cases of Lassa fever during the 2016 outbreak in Nigeria to determine factors associated with mortality. We activated an incident command system to coordinate response.
RESULTS: We documented 47 cases, 28 of whom died (case fatality rate [CFR] = 59.6%; mean age 31.4 years; SD = ±18.4 years). The youngest and the oldest were the most likely to die, with 100% mortality in those aged 5 years or younger and those aged 55 years or older. Patients who commenced ribavirin were more likely to survive (odds ratio [OR] = 0.1; 95% confidence interval [CI] = 0.03, 0.50). Fatality rates went from 100% (wave 1) through 69% (wave 2) to 31% (wave 3; χ2 for linear trend: P < .01). Patients admitted to a health care center before incident command system activation were more likely to die (OR = 4.4; 95% CI = 1.1, 17.6). The only pregnant patient in the study died postpartum.
CONCLUSIONS: Effective, coordinated response reduces mortality from public health events. Attention to vulnerable groups during disasters is essential. Public Health Implications. Activating an incident command system improves the outcome of disasters in resource-constrained settings.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29267063      PMCID: PMC5846592          DOI: 10.2105/AJPH.2017.304186

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  10 in total

Review 1.  The Incident Command System: a literature review.

Authors:  Jessica Jensen; Steven Thompson
Journal:  Disasters       Date:  2015-08-13

2.  Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).

Authors:  Nnennaya A Ajayi; Chinedu G Nwigwe; Ben N Azuogu; Benson N Onyire; Elizabeth U Nwonwu; Lawrence U Ogbonnaya; Francis I Onwe; Tobin Ekaete; Stephan Günther; Kingsley N Ukwaja
Journal:  Int J Infect Dis       Date:  2013-07-17       Impact factor: 3.623

3.  Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.

Authors:  Rami Sommerstein; Joel Ramos da Palma; Stephan Olschläger; Andreas Bergthaler; Leticia Barba; Boris P-L Lee; Antonella Pasquato; Lukas Flatz
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

4.  Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone.

Authors:  A Dahmane; J van Griensven; M Van Herp; R Van den Bergh; Y Nzomukunda; J Prior; P Alders; A Jambai; R Zachariah
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-03       Impact factor: 2.184

5.  Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.

Authors:  Danny A Asogun; Donatus I Adomeh; Jacqueline Ehimuan; Ikponmwonsa Odia; Meike Hass; Martin Gabriel; Stephan Olschläger; Beate Becker-Ziaja; Onikepe Folarin; Eric Phelan; Philomena E Ehiane; Veritas E Ifeh; Eghosasere A Uyigue; Yemisi T Oladapo; Ekene B Muoebonam; Osagie Osunde; Andrew Dongo; Peter O Okokhere; Sylvanus A Okogbenin; Mojeed Momoh; Sylvester O Alikah; Odigie C Akhuemokhan; Peter Imomeh; Maxy A C Odike; Stephen Gire; Kristian Andersen; Pardis C Sabeti; Christian T Happi; George O Akpede; Stephan Günther
Journal:  PLoS Negl Trop Dis       Date:  2012-09-27

6.  Ebola virus disease outbreak - Nigeria, July-September 2014.

Authors:  Faisal Shuaib; Rajni Gunnala; Emmanuel O Musa; Frank J Mahoney; Olukayode Oguntimehin; Patrick M Nguku; Sara Beysolow Nyanti; Nancy Knight; Nasir Sani Gwarzo; Oni Idigbe; Abdulsalam Nasidi; John F Vertefeuille
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-10-03       Impact factor: 17.586

7.  An account of the Ebola virus disease outbreak in Nigeria: implications and lessons learnt.

Authors:  Akaninyene Otu; Soter Ameh; Egbe Osifo-Dawodu; Enoma Alade; Susan Ekuri; Jide Idris
Journal:  BMC Public Health       Date:  2017-07-10       Impact factor: 3.295

Review 8.  Lassa fever: another threat from West Africa.

Authors:  Tal Brosh-Nissimov
Journal:  Disaster Mil Med       Date:  2016-04-30

9.  Lassa fever presenting as acute abdomen: a case series.

Authors:  Andrew E Dongo; Emeka B Kesieme; Christopher E Iyamu; Peter O Okokhere; Odigie C Akhuemokhan; George O Akpede
Journal:  Virol J       Date:  2013-04-19       Impact factor: 4.099

10.  Risk maps of Lassa fever in West Africa.

Authors:  Elisabeth Fichet-Calvet; David John Rogers
Journal:  PLoS Negl Trop Dis       Date:  2009-03-03
  10 in total
  17 in total

1.  Evaluating the Biological Role of Lassa Viral Z Protein-Mediated RIG-I Inhibition Using a Replication-Competent Trisegmented Pichinde Virus System in an Inducible RIG-IN Expression Cell Line.

Authors:  Da Di; Qinfeng Huang; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2022-08-01       Impact factor: 6.549

2.  Beyond Lassa Fever: Systemic and structural barriers to disease detection and response in Sierra Leone.

Authors:  Hana Rohan
Journal:  PLoS Negl Trop Dis       Date:  2022-05-19

3.  CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model.

Authors:  Junki Maruyama; Rachel A Reyna; Megumi Kishimoto-Urata; Shinji Urata; John T Manning; Nantian Harsell; Rebecca Cook; Cheng Huang; Janko Nikolich-Zugich; Tomoko Makishima; Slobodan Paessler
Journal:  PLoS Pathog       Date:  2022-05-23       Impact factor: 7.464

4.  Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.

Authors:  Junki Maruyama; Elizabeth J Mateer; John T Manning; Rachel Sattler; Alexey V Seregin; Natalya Bukreyeva; Frank R Jones; Joseph P Balint; Elizabeth S Gabitzsch; Cheng Huang; Slobodan Paessler
Journal:  Vaccine       Date:  2019-09-24       Impact factor: 3.641

5.  Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization.

Authors:  Kathryn M Hastie; Robert W Cross; Stephanie S Harkins; Michelle A Zandonatti; Anatoliy P Koval; Megan L Heinrich; Megan M Rowland; James E Robinson; Thomas W Geisbert; Robert F Garry; Luis M Branco; Erica Ollmann Saphire
Journal:  Cell       Date:  2019-08-08       Impact factor: 66.850

6.  Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.

Authors:  Yíngyún Caì; Masaharu Iwasaki; Brett F Beitzel; Shuīqìng Yú; Elena N Postnikova; Beatrice Cubitt; Lisa Evans DeWald; Sheli R Radoshitzky; Laura Bollinger; Peter B Jahrling; Gustavo F Palacios; Juan C de la Torre; Jens H Kuhn
Journal:  Viruses       Date:  2018-11-20       Impact factor: 5.818

Review 7.  Lassa virus diversity and feasibility for universal prophylactic vaccine.

Authors:  Igor S Lukashevich; Slobodan Paessler; Juan Carlos de la Torre
Journal:  F1000Res       Date:  2019-01-31

Review 8.  Management of Lassa Fever: A Current Update.

Authors:  Ammar Alli; Juan Fernando Ortiz; Stephanie P Fabara; Amrapali Patel; Taras Halan
Journal:  Cureus       Date:  2021-05-02

9.  Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018.

Authors:  Katherine J Siddle; Philomena Eromon; Kayla G Barnes; Samar Mehta; Judith U Oguzie; Ikponmwosa Odia; Stephen F Schaffner; Sarah M Winnicki; Rickey R Shah; James Qu; Shirlee Wohl; Patrick Brehio; Christopher Iruolagbe; John Aiyepada; Eghosa Uyigue; Patience Akhilomen; Grace Okonofua; Simon Ye; Tolulope Kayode; Fehintola Ajogbasile; Jessica Uwanibe; Amy Gaye; Mambu Momoh; Bridget Chak; Dylan Kotliar; Amber Carter; Adrianne Gladden-Young; Catherine A Freije; Omigie Omoregie; Blessing Osiemi; Ekene B Muoebonam; Michael Airende; Rachael Enigbe; Benevolence Ebo; Iguosadolo Nosamiefan; Paul Oluniyi; Mahan Nekoui; Ephraim Ogbaini-Emovon; Robert F Garry; Kristian G Andersen; Daniel J Park; Nathan L Yozwiak; George Akpede; Chikwe Ihekweazu; Oyewale Tomori; Sylvanus Okogbenin; Onikepe A Folarin; Peter O Okokhere; Bronwyn L MacInnis; Pardis C Sabeti; Christian T Happi
Journal:  N Engl J Med       Date:  2018-10-17       Impact factor: 91.245

10.  A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region.

Authors:  Yingyun Cai; Masaharu Iwasaki; Daisuke Motooka; David X Liu; Shuiqing Yu; Kurt Cooper; Randy Hart; Ricky Adams; Tracey Burdette; Elena N Postnikova; Jonathan Kurtz; Marisa St Claire; Chengjin Ye; Jens H Kuhn; Luis Martínez-Sobrido; Juan Carlos de la Torre
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.